Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2020-02-04 | 2020-04-17 | 105259 |
| FLAREX | 0.1% | SUSPENSION | Resolved | 2017-07-13 | 2017-07-27 | 15722 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Resolved | 2019-12-03 | 2020-03-09 | 100125 |
| TEGRETOL CR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-02 | 2017-12-13 | 27924 |
| PATADAY | 0.2% | SOLUTION | Resolved | 2019-05-07 | 2019-06-19 | 83364 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2018-10-23 | 2018-11-07 | 65471 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-01-25 | 2019-03-13 | 73545 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-05-07 | 2020-09-08 | 83368 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2021-06-04 | 2022-01-04 | 140457 |
| ARZERRA | 100MG | SOLUTION | Resolved | 2017-03-23 | 2018-10-17 | 4096 |
| ARZERRA | 1000MG | SOLUTION | Resolved | 2017-03-23 | 2018-09-27 | 4093 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2018-08-24 | 2018-12-13 | 58947 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2022-06-09 | 2022-10-17 | 162289 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2023-04-13 | 2023-05-19 | 189506 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-04-18 | 2018-04-20 | 46280 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-08-28 | 2018-10-04 | 59387 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2019-08-13 | 2019-11-07 | 91488 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2022-01-12 | 2024-04-05 | 152583 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2023-10-23 | 2024-03-06 | 207835 |
| AFINITOR | 7.5MG | TABLET | Resolved | 2018-05-24 | 2018-07-10 | 50215 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |